<?xml version='1.0' encoding='UTF-8' standalone='yes'?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Heterocyclic Communications</title>
  <link href="https://www.degruyterbrill.com/journal/key/hc/31/1/html" rel="via"/>
  <link href="https://raw.githubusercontent.com/alexander-winkler/degruyter_rss/main/feed/hc.xml" type="application/rss+xml" rel="self"/>
  <link href="https://www.degruyterbrill.com/journal/key/hc/html" rel="related"/>
  <updated>2025-05-06T04:57:02.342019+00:00</updated>
  <id>https://raw.githubusercontent.com/alexander-winkler/degruyter_rss/main/feed/hc.xml</id>
  <generator>https://github.com/alexander-winkler/degruyter_rss/blob/main/degruyter_feedgenerator.py</generator>
  <subtitle>A RSS feed containing the latest articles published in Heterocyclic Communications</subtitle>
  <entry>
    <title>Synthesis, activity exploration, molecular docking, and affinity assessment of theophylline derivatives as inhibitors targeting IDO1</title>
    <link href="https://www.degruyterbrill.com/document/doi/10.1515/hc-2025-0180/html"/>
    <id>https://doi.org/10.1515/hc-2025-0180</id>
    <updated>2025-05-06T04:57:02.342065+00:00</updated>
    <summary>Article by Ziyuan Wu, Songmao Liang, Shunhua Hu, Yimian Wang, Long-Fei Mao, Xixi Hou, Jianxue Yang
DOI: https://doi.org/10.1515/hc-2025-0180</summary>
  </entry>
  <entry>
    <title>Development of heterocyclic-based anticancer agents: A comprehensive review</title>
    <link href="https://www.degruyterbrill.com/document/doi/10.1515/hc-2022-0179/html"/>
    <id>https://doi.org/10.1515/hc-2022-0179</id>
    <updated>2025-05-06T04:57:02.342082+00:00</updated>
    <summary>Article by Mohammed Hadi Ali Al-Jumaili, Ekhlas Aziz Bakr, Mohanad A. Huessien, Ahmed Solaiman Hamed, Mohammed J. Muhaidi
DOI: https://doi.org/10.1515/hc-2022-0179</summary>
  </entry>
</feed>
